As heptelidic acid is expected to act only on tumor cells and immune cells, in particular activated neutrophils [23], this divergent phenotype indicates that the effect of GAPDH down-modulation on immune cells in the host outweighs its inhibitory effect on tumor growth. This evidence concerns the gene GAPDH and neoplasm.